Evidence map›Paper›PMID 35126755›Full record

ArticleJournal of medicine and life

State of hormonal balance in adolescent girls with menstrual function disorders associated with obesity.

Alla Volodymyrivna Borshuliak, Oksana Anatoliivna Andriiets, Oksana Valerianivna Bakun, Anatolii Volodymyrovich Andriiets, Volodymyr Vasyliovich Andriiets, Michael Ivanovicha Sheremet, Valentin Nicolae Varlas

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of medicine and life. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Alla Volodymyrivna BorshuliakKamyanets-Podilsky Medical Professional College, Kamyanets-Podilsky, Ukraine.
Oksana Anatoliivna AndriietsDepartment of Obstetrics and Gynecology, Bukovinian State Medical University, Chernivtsi, Ukraine.
Oksana Valerianivna BakunDepartment of Obstetrics and Gynecology, Bukovinian State Medical University, Chernivtsi, Ukraine.
Anatolii Volodymyrovich AndriietsDepartment of Obstetrics and Gynecology, Bukovinian State Medical University, Chernivtsi, Ukraine.
Volodymyr Vasyliovich AndriietsSurgery department No.1, Bukovinian State Medical University, Chernivtsi, Ukraine.
Michael Ivanovicha SheremetSurgery department No.1, Bukovinian State Medical University, Chernivtsi, Ukraine.
Valentin Nicolae VarlasSurgery department No.1, Bukovinian State Medical University, Chernivtsi, Ukraine.
Bukovinian State Medical University · UACarol Davila University of Medicine and Pharmacy · ROKamianets-Podіlskyi Ivan Ohiienko National University · UA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Investigation of the mechanisms promoting the development of menstrual function disorders associated with obesity in adolescent girls is one of the most important issues of modern medicine. This study included 110 patients. 79 patients aged 12-18 with menstrual disorders associated with obesity were divided into two groups: group 1: 46 patients with apparent signs of hyperandrogenism, group 2: 33 patients without clinical manifestations of hyperandrogenism. The control group included 31 girls of the same age with a regular menstrual cycle. The complex of hormone examination of adolescent girls included determination of serum content: gonadotropic hormones (luteinizing hormone (LH) and follicle-stimulating hormone (FSH), prolactin (PRL), estradiol (E2), testosterone (T), progesterone (PR), dehydroepiandrosterone sulfate; insulin (In) - radioisotope method on a gamma counter "Narcotest" (reagents "IMMUNOTECH", Czech Republic). We identified hyperleptinemia and leptin resistance in patients with menstrual function impairment associated with obesity. In group I, the adiponectin level exceeded the values of the control group (p<0.05). The results revealed a decrease in A/L in group I - 5.4 times compared with patients in group II (p<0.05) and 4.3 times - compared with the control group (p<0.05). The results revealed a decrease in A/L among girls in the group I with MFI associated with obesity - 4.3 times - compared with girls in the control group (p<0,05).

Indexed as

HyperandrogenismPolycystic Ovary SyndromeAdolescentBody Mass IndexChildFemaleFollicle Stimulating HormoneHumansLuteinizing HormoneObesityTestosteroneFollicle Stimulating HormoneLuteinizing HormoneTestosteroneBMI – body mass indexFSH – follicle-stimulating hormonehormone levelshyperandrogenismLH – luteinizing hormonemenstrual functionMFI – menstrual function impairmentobesityPCOS – syndrome of polycystic ovaries

Identifiers

PMID35126755
PMCPMC8811677
OpenAlexW4210926997

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.